Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Wall Street ends down as oil prices, Treasury yields rise
Oncolytics Biotech (ONC:CN) (ONCY) PT Lowered to Cdn$10 at RBC Capital
March 12, 2019 7:27 AM EDTRBC Capital analyst Douglas Miehm lowered the price target on Oncolytics Biotech (ONC:CN) (NASDAQ: ONCY) to Cdn$10.00 (from Cdn$11.00) while maintaining a Outperform rating.
no surprises in Q4/18 results as the company continues to make clinical progress.... More